13F Holdings
中文EN

ACHC Acadia Healthcare Company, Inc.

Services-Specialty Outpatient Facilities, NEC · Nasdaq · SEC CIK 1520697 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.5%
TTM net income YoY-1,150.7%
TTM EPS YoY-1,154.2%
Revenue 3-yr CAGR6.0%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin-33.1%
FCF margin-0.7%
EBITDA margin—

Returns

ROE-43.9%
ROA-18.9%
ROIC (approx.)—
Asset turnover0.57x

Leverage & solvency

Liabilities / assets59.5%
Debt / equity1.16x
Current ratio1.60x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.21x
Accruals ratio-22.8%
Payout ratio—
Capex / revenue7.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$895.31M$865.84M$828.80M$821.46M$851.57M$869.23M$770.50M$774.24M
Pretax income$56.47M$22.01M$10.96M-$1.17B$39.98M$50.00M$13.47M$38.01M
Income tax$17.82M$9.75M$6.50M$7.84M$1.67M$12.07M$4.40M$4.48M
Net income$34.49M$10.93M$4.11M-$1.18B$36.25M$30.13M$8.37M$32.62M
EPS (basic)0.380.120.05—0.400.330.09—
EPS (diluted)0.380.120.05—0.400.330.09—
Weighted avg. shares (diluted)91.75M91.37M90.86M—90.58M90.44M92.04M—
Banking
Net interest income-$37.28M-$38.18M-$38.33M-$37.92M-$36.62M-$35.14M-$29.18M-$30.07M
Balance sheet
Cash & equivalents$163.31M$171.29M$158.47M$133.24M$118.69M$131.42M$91.24M$76.31M
Receivables$501.38M$470.75M$471.75M$440.60M$430.84M$408.54M$396.63M$365.34M
Inventory$6.25M$6.26M$5.93M$5.69M$6.25M$5.82M$5.71M$5.65M
Current assets$881.32M$845.29M$837.20M$814.14M$747.96M$691.56M$638.95M$577.49M
PP&E, net$3.05B$3.09B$3.11B$3.11B$3.09B$3.06B$2.96B$2.85B
Goodwill$1.32B$1.30B$1.30B$1.30B$2.29B$2.28B$2.28B$2.26B
Intangibles$100.19M$100.19M$98.58M$96.67M$85.18M$79.47M$78.83M$70.00M
Total assets$5.55B$5.55B$5.55B$5.53B$6.41B$6.31B$6.15B$5.96B
Current liabilities$552.03M$537.58M$489.36M$525.19M$517.92M$523.71M$473.35M$577.92M
Short-term debt$32.50M$32.50M$32.50M$28.44M$24.38M$20.31M$16.25M$76.82M
Long-term debt$2.32B$2.38B$2.49B$2.47B$2.28B$2.25B$2.18B$1.88B
Total debt$2.35B$2.41B$2.53B$2.50B$2.31B$2.27B$2.20B$1.96B
Total liabilities$3.30B$3.35B$3.38B$3.39B$3.12B$3.08B$2.97B$2.77B
Shareholders' equity$2.02B$1.98B$1.96B$1.95B$3.12B$3.08B$3.04B$3.07B
Net debt$2.19B$2.24B$2.37B$2.37B$2.19B$2.14B$2.11B$1.88B
Shares outstanding90.91M90.87M90.76M90.45M90.43M90.39M90.39M91.78M
Cash flow statement
Operating cash flow$97.88M$162.07M$61.53M-$86.29M$73.21M$133.50M$11.48M$116.70M
Capital expenditure$50.74M$38.55M$76.56M$93.19M$136.24M$167.75M$174.63M$203.49M
Free cash flow$47.14M$123.51M-$15.03M-$179.48M-$63.03M-$34.24M-$163.15M-$86.79M
Investing cash flow-$42.51M-$32.68M-$60.21M-$92.44M-$129.75M-$150.78M-$183.24M-$203.33M
Financing cash flow-$63.36M-$116.57M$23.91M$193.28M$43.82M$57.46M$186.69M$80.79M
Depreciation & amortization$53.13M$50.43M$52.43M$45.75M$47.47M$48.99M$47.03M$39.54M
Stock-based compensation$9.25M$10.99M$7.96M$6.45M$6.03M$10.55M$8.68M$10.10M
Share buybacks———$0$0$3.15M$46.88M—

Free plan shows the latest 8 periods; Pro shows all 65 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.